- Home
- Publications
- Publication Search
- Publication Details
Title
Serotonin, β-amyloid, and cognition in Parkinson disease
Authors
Keywords
-
Journal
ANNALS OF NEUROLOGY
Volume 83, Issue 5, Pages 994-1002
Publisher
Wiley
Online
2018-04-18
DOI
10.1002/ana.25236
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Impact of SSRI Therapy on Risk of Conversion From Mild Cognitive Impairment to Alzheimer’s Dementia in Individuals With Previous Depression
- (2018) Claudia Bartels et al. AMERICAN JOURNAL OF PSYCHIATRY
- Severity of Depression Impacts Imminent Conversion from Mild Cognitive Impairment to Alzheimer’s Disease
- (2017) Michaela Defrancesco et al. JOURNAL OF ALZHEIMERS DISEASE
- Clinical variables and biomarkers in prediction of cognitive impairment in patients with newly diagnosed Parkinson's disease: a cohort study
- (2017) Anette Schrag et al. LANCET NEUROLOGY
- Cognitive decline in Parkinson disease
- (2017) Dag Aarsland et al. Nature Reviews Neurology
- SNPs in Aβ clearance proteins
- (2017) Kathrin Brockmann et al. NEUROLOGY
- Decrease in Aβ42 predicts dopa-resistant gait progression in early Parkinson disease
- (2017) Lynn Rochester et al. NEUROLOGY
- The antidepressant bupropion is a negative allosteric modulator of serotonin type 3A receptors
- (2017) Akash Pandhare et al. NEUROPHARMACOLOGY
- A tricyclic antidepressant, amoxapine, reduces amyloid-β generation through multiple serotonin receptor 6-mediated targets
- (2017) Xiaohang Li et al. Scientific Reports
- The association of antidepressant drug usage with cognitive impairment or dementia, including Alzheimer disease: A systematic review and meta-analysis
- (2016) John Moraros et al. DEPRESSION AND ANXIETY
- Use of antidepressants in Parkinson's disease: A Swedish register-based study of over 1.5 million older people
- (2016) Ylva Haasum et al. PARKINSONISM & RELATED DISORDERS
- Cognitive performances and DAT imaging in early Parkinson's disease with mild cognitive impairment: a preliminary study
- (2015) M. T. Pellecchia et al. ACTA NEUROLOGICA SCANDINAVICA
- CSF β-Amyloid 1-42 Predicts Progression to Cognitive Impairment in Newly Diagnosed Parkinson Disease
- (2015) Mark Terrelonge et al. JOURNAL OF MOLECULAR NEUROSCIENCE
- Plasma and cerebrospinal fluid amyloid-β levels in late-life depression: A systematic review and meta-analysis
- (2015) Kenia Kelly Fiaux do Nascimento et al. JOURNAL OF PSYCHIATRIC RESEARCH
- Amyloid deposition in Parkinson's disease and cognitive impairment: A systematic review
- (2015) Myria Petrou et al. MOVEMENT DISORDERS
- Striatal and Cortical β-Amyloidopathy and Cognition in Parkinson's Disease
- (2015) Neha Shah et al. MOVEMENT DISORDERS
- Molecular Mechanisms of Alzheimer Disease Protection by the A673T Allele of Amyloid Precursor Protein
- (2014) Janice A. Maloney et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The Impact of Antidepressant Treatment on Cognitive Functioning in Depressed Patients with Parkinson’s Disease
- (2014) Roseanne DeFronzo Dobkin et al. JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES
- Longitudinal Change in CSF Biomarkers in Autosomal-Dominant Alzheimer's Disease
- (2014) A. M. Fagan et al. Science Translational Medicine
- An Antidepressant Decreases CSF A Production in Healthy Individuals and in Transgenic AD Mice
- (2014) Y. I. Sheline et al. Science Translational Medicine
- Striatal and extrastriatal dopamine transporter levels relate to cognition in Lewy body diseases: an 11C altropane positron emission tomography study
- (2014) Marta Marquie et al. Alzheimers Research & Therapy
- St. John's Wort Reduces Beta-Amyloid Accumulation in a Double Transgenic Alzheimer's Disease Mouse Model-Role of P-Glycoprotein
- (2013) Anja Brenn et al. BRAIN PATHOLOGY
- Cerebral Amyloid Deposition and Serotoninergic Innervation in Parkinson Disease
- (2012) Vikas Kotagal et al. ARCHIVES OF NEUROLOGY
- β-amyloid and postural instability and gait difficulty in Parkinson's disease at risk for dementia
- (2012) Martijn L.T.M. Müller et al. MOVEMENT DISORDERS
- A randomized, double-blind, placebo-controlled trial of antidepressants in Parkinson disease
- (2012) I. H. Richard et al. NEUROLOGY
- A -amyloid deposition in patients with Parkinson disease at risk for development of dementia
- (2012) M. Petrou et al. NEUROLOGY
- Do continued antidepressants protect against dementia in patients with severe depressive disorder?
- (2011) Lars Vedel Kessing et al. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
- Activation of α-secretase cleavage
- (2011) Rolf Postina JOURNAL OF NEUROCHEMISTRY
- Serotonin signaling is associated with lower amyloid- levels and plaques in transgenic mice and humans
- (2011) J. R. Cirrito et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The Parkinson Progression Marker Initiative (PPMI)
- (2011) Kenneth Marek et al. PROGRESS IN NEUROBIOLOGY
- Staging of serotonergic dysfunction in Parkinson's Disease: An in vivo 11C-DASB PET study
- (2010) Marios Politis et al. NEUROBIOLOGY OF DISEASE
- Striatal Aβ peptide deposition mirrors dementia and differentiates DLB and PDD from other Parkinsonian syndromes
- (2010) M.E. Kalaitzakis et al. NEUROBIOLOGY OF DISEASE
- Antidepressants and dementia
- (2009) Lars Vedel Kessing et al. JOURNAL OF AFFECTIVE DISORDERS
- Validity of the MoCA and MMSE in the detection of MCI and dementia in Parkinson disease
- (2009) S. Hoops et al. NEUROLOGY
- A controlled trial of antidepressants in patients with Parkinson disease and depression
- (2008) M. Menza et al. NEUROLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started